VasoGenix's Other Investors

VasoGenix raised a round of funding on , .

Heart Failure is the single most expensive medical expense in the United States and affects five million people with 550,000 new patients annually. It is responsible for 250,000 deaths annually, more …

Articles about VasoGenix's Other Investors: